[Antiarrhythmic drugs].
D000404:Ajmaline / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004206:Disopyramide / Q000627:therapeutic use; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D006919:Hydroxyzine / Q000627:therapeutic use; D008012:Lidocaine / Q000627:therapeutic use; D011342:Procainamide / Q000009:adverse effects / Q000627:therapeutic use; D011802:Quinidine / Q000009:adverse effects / Q000627:therapeutic use; D013575:Syncope / Q000139:chemically induced
D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D000404:Ajmaline; D006919:Hydroxyzine; D008012:Lidocaine; D004206:Disopyramide; D011802:Quinidine; D011342:Procainamide
Les drogues anti-arythmiques.